CD8A and Epstein-Barr virus infection: Several lines of evidence suggest that EBV-specific CD8 T cells are important for the control of EBV long term (51), including successful treatment of EBV-associated lymphoproliferative disorders and post-transplant associated EBV infections by adoptive transfer of EBV-specific CD8 T cells (52, 53).